EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cardiovascular human organ‐on‐a‐chip platform for disease modeling, drug development, and personalized therapy

Astha Khanna, Beu P Oropeza, Ngan F Huang iD

Journal of Biomedical Materials Research Part A · 2024

DOI: 10.1002/jbm.a.37602 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biomedical Materials Research Part A, 2024. Verfasst von Astha Khanna und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graver Technologies, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Microphysiological Systems, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, FDA HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular organ‐on‐a‐chip (OoC) devices are composed of engineered or native functional tissues that are cultured under controlled microenvironments inside microchips. These systems employ microfabrication and tissue engineering techniques to recapitulate human physiology. This review focuses on human OoC systems to model cardiovascular diseases, to perform drug screening, and to advance personalized medicine. We also address the challenges in the generation of organ chips that can revolutionize the large‐scale application of these systems for drug development and personalized therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microphysiological SystemsLab-On-A-Chip DevicesHumansDrug DevelopmentTissue EngineeringDrug Evaluation, Preclinical

Stichwörter der Autor:innen

biomaterialscardiovascularorgan-on-a-chiporganoidstem cell

Autor:innen und Institutionen

  • Graver Technologies, Newark, New Jersey, USA.
  • Department of Cardiothoracic Surgery, Stanford University, Stanford, California, USA.
  • Stanford Cardiovascular Institute, Stanford University, Stanford, California, USA.
  • Center for Tissue Regeneration, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
  • Department of Chemical Engineering, Stanford University, Stanford, California, USA.

ORCID-Profile: Ngan F Huang

Förderung

  • NHLBI NIH HHS
  • FDA HHS
  • BLRD VA
  • RRD VA
  • American Heart Association
  • National Science Foundation
  • National Institutes of Health

Zitieren

APA

Khanna, A., Oropeza, B. P., & Huang, N. F. (2024). Cardiovascular human organ‐on‐a‐chip platform for disease modeling, drug development, and personalized therapy. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37602

Vancouver

Khanna A, Oropeza BP, Huang NF. Cardiovascular human organ‐on‐a‐chip platform for disease modeling, drug development, and personalized therapy. Journal of Biomedical Materials Research Part A. 2024. doi:10.1002/jbm.a.37602

BibTeX
@article{Khanna2024,
  author = {Khanna, Astha and Oropeza, Beu P and Huang, Ngan F},
  title = {Cardiovascular human organ‐on‐a‐chip platform for disease modeling, drug development, and personalized therapy},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2024},
  doi = {10.1002/jbm.a.37602}
}
Kostenlos starten →